Norges Bank
TEVA icon

Norges Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Norges Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09B Buy
+32,299,753
New +$1.08B 0.11% 157
2026
Q1 		– Sell
-35,182,949
Closed -$1.1B – 1260
2025
Q4 		$1.1B Buy
+35,182,949
New +$867M 0.12% 145
2025
Q3 		– Sell
-1,864,684
Closed -$31.3M – 1404
2025
Q2 		$31.3M Sell
1,864,684
-720,516
-28% -$11.6M ﹤0.01% 1107
2025
Q1 		$39.7M Buy
2,585,200
+836,130
+48% +$14.9M 0.01% 1029
2024
Q4 		$38.5M Buy
1,749,070
+233,000
+15% +$4.24M 0.01% 1062
2024
Q3 		$27.3M Buy
1,516,070
+442,169
+41% +$7.74M ﹤0.01% 1171
2024
Q2 		$17.5M Buy
1,073,901
+468,901
+78% +$7.22M ﹤0.01% 1251
2024
Q1 		$8.54M Sell
605,000
-772,000
-56% -$9.73M ﹤0.01% 1497
2023
Q4 		$14.4M Buy
1,377,000
+334,000
+32% +$3.12M ﹤0.01% 1365
2023
Q3 		$10.6M Sell
1,043,000
-10,100,027
-91% -$94M ﹤0.01% 1447
2023
Q2 		$83.9M Buy
11,143,027
+7,840,027
+237% +$63.6M 0.02% 629
2023
Q1 		$29.2M Buy
3,303,000
+2,190,000
+197% +$21.7M 0.01% 1086
2022
Q4 		$10.2M Buy
1,113,000
+218,000
+24% +$1.9M ﹤0.01% 1569
2022
Q3 		$7.22M Buy
895,000
+585,000
+189% +$5.17M ﹤0.01% 1647
2022
Q2 		$2.33M Buy
+310,000
New +$2.7M ﹤0.01% 1884
2022
Q1 		– Sell
-150,316
Closed -$1.2M – 2233
2021
Q4 		$1.2M Sell
150,316
-150,997
-50% -$1.36M ﹤0.01% 2085
2021
Q3 		$2.94M Sell
301,313
-2,336,447
-89% -$21.9M ﹤0.01% 1997
2021
Q2 		$26.1M Hold
2,637,760
– – 0.01% 1374
2021
Q1 		$30.4M Sell
2,637,760
-443,244
-14% -$5.08M 0.01% 1282
2020
Q4 		$29.7M Buy
3,081,004
+304,259
+11% +$2.91M 0.01% 1322
2020
Q3 		$25M Buy
2,776,745
+955,058
+52% +$10.1M 0.01% 1270
2020
Q2 		$22.5M Sell
1,821,687
-6,655,565
-79% -$75.3M 0.01% 1360
2020
Q1 		$76.1M Hold
8,477,252
– – 0.03% 531
2019
Q4 		$83.1M Buy
8,477,252
+208,256
+3% +$1.86M 0.02% 629
2019
Q3 		$56.9M Hold
8,268,996
– – 0.02% 795
2019
Q2 		$76.3M Sell
8,268,996
-941,020
-10% -$11.3M 0.02% 635
2019
Q1 		$144M Sell
9,210,016
-266,666
-3% -$4.7M 0.05% 370
2018
Q4 		$146M Sell
9,476,682
-452,958
-5% -$9.29M 0.05% 321
2018
Q3 		$214M Sell
9,929,640
-265,835
-3% -$6.17M 0.07% 271
2018
Q2 		$248M Buy
10,195,475
+1,000,000
+11% +$20.4M 0.09% 235
2018
Q1 		$157M Hold
9,195,475
– – 0.06% 322
2017
Q4 		$174M Sell
9,195,475
-563,437
-6% -$8.48M 0.06% 308
2017
Q3 		$172M Sell
9,758,912
-1,508,375
-13% -$33.9M 0.07% 299
2017
Q2 		$374M Sell
11,267,287
-169,683
-1% -$5.25M 0.15% 136
2017
Q1 		$367M Sell
11,436,970
-2,243,263
-16% -$76.6M 0.15% 136
2016
Q4 		$496M Sell
13,680,233
-378,373
-3% -$15.1M 0.22% 87
2016
Q3 		$618M Sell
14,058,606
-329,033
-2% -$17.2M 0.29% 65
2016
Q2 		$723M Buy
14,387,639
+2,507,844
+21% +$134M 0.34% 54
2016
Q1 		$636M Buy
11,879,795
+1,492,054
+14% +$87.5M 0.31% 58
2015
Q4 		$682M Buy
10,387,741
+1,000,000
+11% +$61.8M 0.34% 56
2015
Q3 		$530M Hold
9,387,741
– – 0.28% 70
2015
Q2 		$555M Sell
9,387,741
-1,117,967
-11% -$69M 0.28% 69
2015
Q1 		$655M Buy
10,505,708
+876,271
+9% +$50.9M 0.32% 59
2014
Q4 		$554M Buy
9,629,437
+193,949
+2% +$10.8M 0.28% 70
2014
Q3 		$507M Sell
9,435,488
-9,435,488
-50% -$500M 0.27% 69
2014
Q2 		$989M Buy
18,870,976
+11,149,988
+144% +$570M 0.27% 76
2014
Q1 		$408M Hold
7,720,988
– – 0.23% 85
2013
Q4 		$309M Hold
7,720,988
– – 0.18% 116
2013
Q3 		$292M Sell
7,720,988
-651,303
-8% -$25.4M 0.17% 118
2013
Q2 		$328M Buy
+8,372,291
New +$326M 0.2% 102

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank's TEVA Position: Q2 2026 in Review

Norges Bank opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 32,299,753 shares worth $1.09B. The stake represents 0.11% of the portfolio and ranks #157 among its holdings. This is a return to the name: Norges Bank previously reported a position in TEVA as recently as Q4 2025.

Norges Bank first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.1B in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Norges Bank held 32,299,753 shares of Teva Pharmaceuticals worth $1.09B as of Q2 2026.
  • Teva Pharmaceuticals was a new Norges Bank position in Q2 2026.
  • Teva Pharmaceuticals made up 0.11% of Norges Bank's portfolio in Q2 2026, its #157 holding.
  • Norges Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Norges Bank's Teva Pharmaceuticals position peaked at $1.1B in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.